Description
LL-37, the only human cathelicidin, is a 37-amino acid peptide that serves as a critical component of the innate immune system. Its primary mechanism of action involves the disruption of microbial membranes. The peptide’s cationic nature allows it to selectively bind to and permeabilize the negatively charged membranes of bacteria, fungi, and some viruses, leading to cell death. Beyond its direct antimicrobial activity, LL-37 exhibits a wide range of immunomodulatory functions. It can chemoattract immune cells, such as neutrophils and monocytes, to sites of infection and inflammation. Furthermore, LL-37 can modulate inflammatory responses, influence cytokine production, and promote wound healing and angiogenesis. Key research areas for LL-37 include its potential as a therapeutic agent for infectious diseases, its role in inflammatory and autoimmune conditions like psoriasis and lupus, and its emerging connection to cancer biology. This product is intended for research purposes only and is not for human consumption.
CAS: 154947-66-7
PubChem CID: 16198951
Molecular Formula: C205H340N60O53
Molecular Weight: 4493.37 g/mol
Amino Acid Sequence: LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES (37 aa)
Physical Form: Lyophilized Powder
Purity: ≥99%
Storage: -20°C, protected from light and moisture

